Lisa Schlesinger

Lisa Schlesinger, RN, currently serves as Vice President of New Product Development and Market Access at Protara Therapeutics since June 2024. Prior to this role, Lisa held the position of Director of Trade and Reimbursement at Sage Therapeutics from July 2018. Experience includes serving as Director of National Accounts at Vyera Pharmaceuticals, LLC, where a Managed Care Strategy was developed and implemented. Lisa was also Vice President of Market Access at Entera Health, executing a National Account strategy, and held multiple roles at Cubist Pharmaceuticals as Director of National Accounts from May 2004 to January 2015. Earlier in the career, Lisa worked as a Clinical Sales Liaison at Coram CVS/specialty infusion services, providing clinical and sales support from March 2002 to March 2004.